Patents by Inventor Bryon W. Petschow

Bryon W. Petschow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9439885
    Abstract: The present invention is directed to a method for inhibiting the growth of pathogenic bacteria in an infant formula comprising supplementing the infant formula with at least one diglyceride antimicrobial agent.
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: September 13, 2016
    Assignee: Mead Johnson Nutrition Company
    Inventor: Bryon W. Petschow
  • Patent number: 8557320
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: September 4, 2012
    Date of Patent: October 15, 2013
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20120328585
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: September 4, 2012
    Publication date: December 27, 2012
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Patent number: 8277863
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: October 2, 2012
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20090311379
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: July 2, 2009
    Publication date: December 17, 2009
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20090298937
    Abstract: The present invention is directed to a method for inhibiting the growth of pathogenic bacteria in an infant formula comprising supplementing the infant formula with at least one diglyceride antimicrobial agent.
    Type: Application
    Filed: April 24, 2009
    Publication date: December 3, 2009
    Applicant: MEAD JOHNSON NUTRITION COMPANY
    Inventor: Bryon W. Petschow
  • Patent number: 7572474
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Grant
    Filed: June 30, 2005
    Date of Patent: August 11, 2009
    Assignee: Mead Johnson Nutrition Company
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glen R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20090176734
    Abstract: The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.
    Type: Application
    Filed: February 12, 2009
    Publication date: July 9, 2009
    Applicant: Mead Johnson & Co.
    Inventors: Bryon W. Petschow, Robert J. McMahon, Glenn R. Gibson, Robert A. Rastall, Renia Gemmell, Maria Saarela, Anna-Marja Aura
  • Publication number: 20080095752
    Abstract: The invention involves a method for extending the shelf life of a powdered nutritional formulation that contains LGG by reducing and maintaining a threshold water activity or moisture content in the powdered LGG-containing formulation.
    Type: Application
    Filed: October 20, 2006
    Publication date: April 24, 2008
    Inventors: Win-Chin Chiang, Bryon W. Petschow, Adrie Baars, Yung H. Lee, Luis Jose Montelongo, Nagendra Rangavajla
  • Patent number: 5660842
    Abstract: The present invention is directed to a method for inhibiting Helicobacter by administering C.sub.8 -C.sub.16 monoglycerides of fatty acids or lauric acid. The monoglycerides and/or lauric acid are conveniently administered via a nutritional composition.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: August 26, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventor: Bryon W. Petschow
  • Patent number: 5550106
    Abstract: A low buffer nutritional composition which is useful to reduce the incidence of colonization of pathogenic bacteria.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: August 27, 1996
    Assignee: Bristol-Myers Squibb Company
    Inventors: Bryon W. Petschow, Yung-Hsiung Lee